Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Anti-HCMV pseudopeptides disclosed by Bayer

Oct. 30, 1997

Diester prodrugs of antiviral acyclic nucleoside disclosed by Medivir

Oct. 29, 1997

Lamisil's safety profile confirmed

Oct. 28, 1997

Sankyo isolates antibacterial agent F-12436

Oct. 23, 1997

PathoGenesis initiates phase II trial with new antiinfective for tuberculosis

Oct. 22, 1997

New nonimmunosuppressive CsA derivative with potent anti-Toxoplasma activity

Oct. 22, 1997

Taisho, Abbott to collaborate on macrolide antibacterials

Oct. 21, 1997

NIH researcher outlines ups and downs of malaria vaccine research

Oct. 21, 1997

Anti-Infective Drugs Advisory Committee to discuss three NDAs

Oct. 20, 1997

Viragen considers genital herpes as possible target for Omniferon

Oct. 20, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...